| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $75.0M | +117.6% |
| Cost of Revenue | $37.9M | +103.8% |
| Gross Profit | $37.1M | +133.8% |
| R&D Expense | $29.0M | +52.6% |
| SG&A Expense | $88.8M | +74.0% |
| Operating Income | -$80.7M | -49.0% |
| Interest Expense | $5.2M | -10.8% |
| Income Tax | $0 | — |
| Net Income | -$87.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $221.9M | -27.1% |
| Accounts Receivable | $15.3M | +242.1% |
| Inventory | $28.5M | +117.1% |
| Current Assets | $272.6M | -16.4% |
| Total Assets | $309.3M | -8.2% |
| Current Liabilities | $35.3M | +117.3% |
| Long-term Debt | $51.2M | +2.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$80.4M | -40.2% |
| Capital Expenditures | $2.7M | +348.1% |
| Investing Cash Flow | -$2.7M | -348.1% |
| Financing Cash Flow | $3.6M | -98.6% |
| Free Cash Flow | -$83.0M | -43.3% |
| -45.6% |
| EPS (Basic) | -$1.96 | +46.0% |
| EPS (Diluted) | -$1.96 | +46.0% |
| Total Liabilities |
| $112.3M |
| +60.5% |
| Stockholders' Equity | $197.1M | -26.2% |